Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

O Thomas Daniel


  • Director at Zafgen Inc. (ZFGN), 2019-06-27
  • Director at Gossamer Bio Inc. (GOSS), 2019-06-11
  • Director at Magenta Therapeutics Inc. (MGTA), 2019-06-11
  • Director at Juno Therapeutics Inc. (JUNO), 2018-03-07
  • See Remarks at Celgene Corp (CELG), 2016-02-02
  • Director at Epizyme Inc. (EPZM), 2013-05-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CELG $130.82 25,578 Officer 62,178 2015-08-10 Filing
CELG $133.96 29,720 Officer 55,532 2015-07-28 Filing
CELG $120.78 30,156 Officer 55,532 2015-07-13 Filing
CELG $115.06 30,000 Officer 45,400 2014-12-15 Filing
CELG $110.27 33,818 Officer 45,400 2014-11-24 Filing